{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "antioxidant", "cholinesterase", "glucosidase", "molecular docking", "succinimides"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32606589", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "30"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S237420"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2020"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Comparative Cholinesterase, \u03b1-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.", "Pagination": {"StartPage": "2165", "EndPage": "2178", "MedlinePgn": "2165-2178"}, "Abstract": {"AbstractText": ["The current study was designed to synthesize derivatives of succinimide and compare their biological potency in anticholinesterase, alpha-glucosidase inhibition, and antioxidant assays.", "In this research, two succinimide derivatives including (<i>S</i>)-1-(2,5-dioxo-1-phenylpyrrolidin-3-yl) cyclohexanecarbaldehyde (Compound <b>1</b>) and (<i>R</i>)-2-((<i>S</i>)-2,5-dioxo-1-phenylpyrrolidin-3-yl)-2-phenylpropanal (Compound <b>2</b>) were synthesized using Michael addition. Both the compounds, ie, <b>1</b> and <b>2</b> were evaluated for in-vitro acetylcholinesterase (AChE), butyrylctcholinesterase (BChE), antioxidant, and \u03b1-glucosidase inhibitory potentials. Furthermore, molecular docking was performed using Molecular Operating Environment (MOE) to explore the binding mode of both the compounds against different enzymes. Lineweaver-Burk plots of enzyme inhibitions representing the reciprocal of initial enzyme velocity versus the reciprocal of substrate concentration in the presence of synthesized compounds and standard drugs were constructed using Michaelis-Menten kinetics.", "In AChE inhibitory assay, compounds <b>1</b> and <b>2</b> exhibited IC<sub>50</sub> of 343.45 and 422.98 \u00b5M, respectively, against AChE enzyme. Similarly, both the compounds showed IC<sub>50</sub> of 276.86 and 357.91 \u00b5M, respectively, against BChE enzyme. Compounds <b>1</b> and <b>2</b> displayed IC<sub>50</sub> of 157.71 and 471.79 \u00b5M against \u03b1-glucosidase enzyme, respectively. In a similar pattern, compound <b>1</b> exhibited to be more potent as compared to compound <b>2</b> in all the three antioxidant assays. Compound <b>1</b> exhibited IC<sub>50</sub> values of 297.98, 332.94, and 825.92 \u00b5M against DPPH, ABTS, and H<sub>2</sub>O<sub>2</sub> free radicals, respectively. Molecular docking showed a triple fold in the AChE and BChE activity for compound <b>1</b> compared with compound <b>2</b>. The compound\u00a01\u00a0revealed good interaction against both the AChE and BChE enzymes which revealed the high potency of this compound compared to compound\u00a0<b>2</b>.", "Both succinimide derivatives exhibited considerable inhibitory activities against cholinesterases and \u03b1-glucosidase enzymes. Of these two, compound <b>1</b> revealed to be more potent against all the in-vitro targets which was supported by molecular docking with the lowest binding energies. Moreover, compound <b>1</b> also proved to have antiradical properties."], "CopyrightInformation": "\u00a9 2020 Ahmad et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science & Technology, Peshawar, KPK, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000, KP, Pakistan."}], "LastName": "Ahmad", "ForeName": "Ashfaq", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000, KP, Pakistan."}], "LastName": "Ullah", "ForeName": "Farhat", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000, KP, Pakistan."}], "LastName": "Sadiq", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": ["0000-0002-4299-2445"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000, KP, Pakistan."}], "LastName": "Ayaz", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0003-2411-6510"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000, KP, Pakistan."}], "LastName": "Saeed Jan", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": ["0000-0002-6953-7848"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science & Technology, Peshawar, KPK, Pakistan."}], "LastName": "Shahid", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, UCS, Shankar Abdul Wali Khan University, Mardan 23200, Pakistan."}], "LastName": "Wadood", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science & Technology, Peshawar, KPK, Pakistan."}], "LastName": "Mahmood", "ForeName": "Fawad", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan."}], "LastName": "Rashid", "ForeName": "Umer", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Medicinal, Aromatic and Poisonous Plants Research Center (MAPRC), College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia."}], "LastName": "Ullah", "ForeName": "Riaz", "Initials": "R"}, {"Identifier": ["0000-0002-9768-4255"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Sarhad University of Science & Technology, Peshawar, KPK, Pakistan."}], "LastName": "Sahibzada", "ForeName": "Muhammad Umar Khayam", "Initials": "MUK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Medicinal, Aromatic and Poisonous Plants Research Center (MAPRC), College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": ["0000-0001-9215-0505"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Mahmood", "ForeName": "Hafiz Majid", "Initials": "HM"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzothiazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Biphenyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Picrates"}, {"RegistryNumber": "0", "NameOfSubstance": "Succinimides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonic Acids"}, {"RegistryNumber": "10X90O3503", "NameOfSubstance": "succinimide"}, {"RegistryNumber": "28752-68-3", "NameOfSubstance": "2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid"}, {"RegistryNumber": "DFD3H4VGDH", "NameOfSubstance": "1,1-diphenyl-2-picrylhydrazyl"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Cholinesterases"}, {"RegistryNumber": "EC 3.2.1.20", "NameOfSubstance": "alpha-Glucosidases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["analysis"], "DescriptorName": "Benzothiazoles"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Biphenyl Compounds"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholinesterases"}, {"QualifierName": [], "DescriptorName": "Electrophorus"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Horses"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Picrates"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Succinimides"}, {"QualifierName": ["analysis"], "DescriptorName": "Sulfonic Acids"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Glucosidases"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sadiq A, Zeb A, Ullah F, et al. Chemical characterization, analgesic, antioxidant, and anticholinesterase potentials of essential oils from Isodon rugosus wall. ex. Benth. Front Pharmacol. 2018;9.", "ArticleIdList": ["PMC6008688", "29950997"]}, {"Citation": "Ayaz M, Sadiq A, Junaid M, et al. Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front Aging Neurosci. 2019;11:155. doi:10.3389/fnagi.2019.00155", "ArticleIdList": ["10.3389/fnagi.2019.00155", "PMC6606780", "31293414"]}, {"Citation": "Ovais M, Zia N, Ahmad I, et al. phyto-therapeutic and nanomedicinal approach to cure Alzheimer disease: present status and future opportunities. Front Aging Neurosci. 2018;10:284. doi:10.3389/fnagi.2018.00284", "ArticleIdList": ["10.3389/fnagi.2018.00284", "PMC6205985", "30405389"]}, {"Citation": "Zafar R. et al. Zinc metal carboxylates as potential anti-Alzheimer\u2019s candidate: in-vitro anticholinesterase, antioxidant and molecular docking studies. J Biomol Struct Dyn. 2020;1\u201315. doi:10.1080/07391102.2020.1724569", "ArticleIdList": ["10.1080/07391102.2020.1724569", "32013770"]}, {"Citation": "Loveman E, Green C, Kirby J, et al. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer\u2019s disease. Health Tech Assess. 2006;10. doi:10.3310/hta10010", "ArticleIdList": ["10.3310/hta10010", "16409879"]}, {"Citation": "Ayaz M, Sadiq A, Junaid M, Ullah F, Subhan F, Ahmed J. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front Aging Neurosci. 2017;9:168. doi:10.3389/fnagi.2017.00168", "ArticleIdList": ["10.3389/fnagi.2017.00168", "PMC5447774", "28611658"]}, {"Citation": "Ayaz M, Sadiq A, Junaid M, et al. Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front Aging Neurosci. 2019;11.", "ArticleIdList": ["PMC6606780", "31293414"]}, {"Citation": "Ayaz M, Ullah F, Sadiq A, Kim MO, Ali T. Natural products-based drugs: potential therapeutics against Alzheimer\u2019s disease and other neurological disorders. Front Pharmacol. 2019;10:1417.", "ArticleIdList": ["PMC6889855", "31849668"]}, {"Citation": "Ahmad S, Zeb A, Ayaz M, Murkovic M. Characterization of phenolic compounds using UPLC\u2013HRMS and HPLC\u2013DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. Leaves. Eur Food Res Tech. 2020;1\u201312."}, {"Citation": "Jabeen M, et al. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives. Steroids. 2020;158:108599. doi:10.1016/j.steroids.2020.108599", "ArticleIdList": ["10.1016/j.steroids.2020.108599", "32126219"]}, {"Citation": "Ayaz M, Junaid M, Ullah F, et al. Anti-Alzheimer\u2019s studies on \u03b2-sitosterol isolated from polygonum hydropiper L. Front Pharmacol. 2017;8:697. doi:10.3389/fphar.2017.00697", "ArticleIdList": ["10.3389/fphar.2017.00697", "PMC5635809", "29056913"]}, {"Citation": "Sultana N, Sarfraz M, Tanoli ST, et al. Synthesis, crystal structure determination, biological screening and docking studies of N1-substituted derivatives of 2, 3-dihydroquinazolin-4 (1H)-one as inhibitors of cholinesterases. Bioorg Chem. 2017;72:256\u2013267. doi:10.1016/j.bioorg.2017.04.009", "ArticleIdList": ["10.1016/j.bioorg.2017.04.009", "28495556"]}, {"Citation": "Ayaz M, Junaid M, Ullah F, et al. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from polygonum hydropiper L: a preliminary anti-Alzheimer\u2019s study. Lipids Health Dis. 2015;14(1):141. doi:10.1186/s12944-015-0145-8", "ArticleIdList": ["10.1186/s12944-015-0145-8", "PMC4632677", "26530857"]}, {"Citation": "Ali M, Muhammad S, Shah MR, et al. Neurologically potent molecules from crataegus oxyacantha; isolation, anticholinesterase inhibition, and molecular docking. Front Pharmacol. 2017;8:327. doi:10.3389/fphar.2017.00327", "ArticleIdList": ["10.3389/fphar.2017.00327", "PMC5461367", "28638340"]}, {"Citation": "Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord. 2013;6(1):19\u201333. doi:10.1177/1756285612461679", "ArticleIdList": ["10.1177/1756285612461679", "PMC3526946", "23277790"]}, {"Citation": "Shah S, Muhammad M, Sadiq A, Shah SMH, Ullah F. Antioxidant, total phenolic contents and antinociceptive potential of teucrium stocksianum methanolic extract in different animal models. BMC Complement Altern Med. 2014;14(1):181. doi:10.1186/1472-6882-14-181", "ArticleIdList": ["10.1186/1472-6882-14-181", "PMC4059475", "24893601"]}, {"Citation": "Ayaz M, Ovais M, Ahmad I, Sadiq A, Khalil AT, Ullah F. Biosynthesized metal nanoparticles as potential Alzheimer\u2019s disease therapeutics. Metal Nanoparticles Drug Delivery Diagn Appl. 2020;31\u201342."}, {"Citation": "Sarfraz M, Sultana N, Rashid U, Akram MS, Sadiq A, Tariq MI. Synthesis, biological evaluation and docking studies of 2, 3-dihydroquinazolin-4 (1H)-one derivatives as inhibitors of cholinesterases. Bioorg Chem. 2017;70:237\u2013244. doi:10.1016/j.bioorg.2017.01.004", "ArticleIdList": ["10.1016/j.bioorg.2017.01.004", "28126287"]}, {"Citation": "Ahmad G, et al. Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl) thiophene-2-carboxamide analogs. Bioorg Chem. 2019;92:103216. doi:10.1016/j.bioorg.2019.103216", "ArticleIdList": ["10.1016/j.bioorg.2019.103216", "31491567"]}, {"Citation": "Eruygur N, Ucar E, Akpulat HA, Shahsavari K, Safavi SM, Kahrizi D. In vitro antioxidant assessment, screening of enzyme inhibitory activities of methanol and water extracts and gene expression in hypericum lydium. Mol Biol Rep. 2019;1\u20139.", "ArticleIdList": ["30762165"]}, {"Citation": "Zohra T, Ovais M, Khalil AT, Qasim M, Ayaz M, Shinwari ZK. Extraction optimization, total phenolic, flavonoid contents, HPLC-DAD analysis and diverse pharmacological evaluations of Dysphania ambrosioides (L.) Mosyakin & Clemants. Nat Prod Res. 2019;33(1):136\u2013142. doi:10.1080/14786419.2018.1437428", "ArticleIdList": ["10.1080/14786419.2018.1437428", "29430965"]}, {"Citation": "Rahim H, Sadiq A, Khan S, et al. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro \u03b1-glucosidase inhibition. Int J Nanomed. 2019;14:6287. doi:10.2147/IJN.S210548", "ArticleIdList": ["10.2147/IJN.S210548", "PMC6689535", "31496686"]}, {"Citation": "Aslam H, Khan A-U, Naureen H, Ali F, Ullah F, Sadiq A. Potential application of Conyza canadensis (L) Cronquist in the management of diabetes: in vitro and in vivo evaluation. Trop J Pharm Res. 2018;17(7):1287\u20131293. doi:10.4314/tjpr.v17i7.9", "ArticleIdList": ["10.4314/tjpr.v17i7.9"]}, {"Citation": "de Melo EB, da Silveira Gomes A, Carvalho I. \u03b1-and \u03b2-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron. 2006;62(44):10277\u201310302. doi:10.1016/j.tet.2006.08.055", "ArticleIdList": ["10.1016/j.tet.2006.08.055"]}, {"Citation": "Barut B, Barut EN, Engin S, \u00d6zel A, Sezen FS. Investigation of the antioxidant, \u03b1-Glucosidase inhibitory, anti-inflammatory, and DNA protective properties of vaccinium arctostaphylos L. Turkish J Pharm Sci. 2019;16:2. doi:10.4274/tjps.galenos.2018.28247", "ArticleIdList": ["10.4274/tjps.galenos.2018.28247", "PMC7227966", "32454711"]}, {"Citation": "Jan MS, Ahmad S, Hussain F, et al. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2, 5-dione derivatives as multitarget anti-inflammatory agents. Eur J Med Chem. 2020;186:111863. doi:10.1016/j.ejmech.2019.111863", "ArticleIdList": ["10.1016/j.ejmech.2019.111863", "31740050"]}, {"Citation": "Hussain F, Khan Z, Jan MS, et al. Synthesis, in-vitro \u03b1-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2, 5-dione and thiazolidine-2, 4-dione derivatives. Bioorg Chem. 2019;91:103128. doi:10.1016/j.bioorg.2019.103128", "ArticleIdList": ["10.1016/j.bioorg.2019.103128", "31369977"]}, {"Citation": "Lovi\u0107 J, Avramov Ivi\u0107 M, B\u0110 B, La\u0111arevi\u0107 J, Mijin D. Voltammetric investigation of inclusion complexes of the selected succinimides with \u03b2-cyclodextrin and (2-hydroxypropyl)-\u03b2-cyclodextrin. Acta Chim Slov. 2019;66:182\u2013189. doi:10.17344/acsi.2018.4767", "ArticleIdList": ["10.17344/acsi.2018.4767", "33855472"]}, {"Citation": "Ahmad A, Ullah F, Sadiq A, et al. Pharmacological evaluation of aldehydic-pyrrolidinedione against HCT-116, MDA-MB231, NIH/3T3, MCF-7 cancer cell lines, antioxidant and enzyme inhibition studies. Drug Des Devel Ther. 2019;13:4185. doi:10.2147/DDDT.S226080", "ArticleIdList": ["10.2147/DDDT.S226080", "PMC6911349", "31849450"]}, {"Citation": "Bibi A, Shah T, Sadiq A, Khalid N, Ullah F, Iqbal A. l-Isoleucine-catalyzed michael synthesis of N-Alkylsuccinimide derivatives and their antioxidant activity assessment. Russian J Organic Chem. 2019;55(11):1749\u20131754. doi:10.1134/S1070428019110174", "ArticleIdList": ["10.1134/S1070428019110174"]}, {"Citation": "Sadiq A, Mahmood F, Ullah F, et al. Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer\u2019s. Chem Cent J. 2015;9(1):31. doi:10.1186/s13065-015-0107-2", "ArticleIdList": ["10.1186/s13065-015-0107-2", "PMC4461796", "26064188"]}, {"Citation": "Mahmood F, Jan MS, Ahmad S, et al. Ethyl 3-oxo-2-(2, 5-dioxopyrrolidin-3-yl) butanoate derivatives: anthelmintic and cytotoxic potentials, antimicrobial, and docking studies. Front Chem. 2017;5:119. doi:10.3389/fchem.2017.00119", "ArticleIdList": ["10.3389/fchem.2017.00119", "PMC5733081", "29312926"]}, {"Citation": "Wang F, Yin H, Yue C, Cheng S, Hong M. Syntheses, structural characterization, in vitro cytotoxicities and DNA-binding properties of triphenylantimony di (N-oxy phthalimide) and di (N-oxy succinimide) complexes. J Organomet Chem. 2013;738:35\u201340. doi:10.1016/j.jorganchem.2013.03.046", "ArticleIdList": ["10.1016/j.jorganchem.2013.03.046"]}, {"Citation": "Patil M, Rajput S. Succinimides: synthesis, reaction, and biological activity. Int J Pharm Pharm Sci. 2014;6(11):8\u201314."}, {"Citation": "Jan MS, Shahid M, Ahmad S, et al. Synthesis of pyrrolidine-2, 5-dione based anti-inflammatory drug: in vitro COX-2, 5-LOX inhibition and in vivo anti-inflammatory studies. Latin Am J Pharm. 2019;38(11):2287\u20132294."}, {"Citation": "Selvakumar V, Duraipandi S, Devdas S. Synthesis and psychopharmacological activities of some succinimide mannich bases. J Pharm Res. 2011;4:3168\u20133170."}, {"Citation": "Nugent TC, Negru DE, El\u2010Shazly M, et al. Sequential reductive amination\u2010hydrogenolysis: a one\u2010pot synthesis of challenging chiral primary amines. Adv Synth Catal. 2011;353(11\u201012):2085\u20132092."}, {"Citation": "Nugent TC, Bibi A, Sadiq A, Mohammad Shoaib M, Umar N, Tehrani FN. Chiral picolylamines for Michael and aldol reactions: probing substrate boundaries. Org Biomol Chem. 2012;10(46):9287\u20139294.", "ArticleIdList": ["23104278"]}, {"Citation": "Iftikhar F, Yaqoob F, Tabassum N, et al. Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines. Bioorg Chem. 2018;80:99\u2013111. doi:10.1016/j.bioorg.2018.05.026", "ArticleIdList": ["10.1016/j.bioorg.2018.05.026", "29894893"]}, {"Citation": "Tanoli ST, Ramzan M, Hassan A, et al. Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors. Bioorg Chem. 2019;83:336\u2013347. doi:10.1016/j.bioorg.2018.10.035", "ArticleIdList": ["10.1016/j.bioorg.2018.10.035", "30399465"]}, {"Citation": "Nugent TC, Sadiq A, Bibi A, et al. Noncovalent bifunctional organocatalysts: powerful tools for contiguous quaternary\u2010tertiary stereogenic carbon formation, scope, and origin of enantioselectivity. Chem a Eur J. 2012;18(13):4088\u20134098. doi:10.1002/chem.201103005", "ArticleIdList": ["10.1002/chem.201103005", "22354747"]}, {"Citation": "Ullah F, Ayaz M, Sadiq A, et al. Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of iris germanica var; florentina. Nat Prod Res. 2016;30(12):1440\u20131444. doi:10.1080/14786419.2015.1057585", "ArticleIdList": ["10.1080/14786419.2015.1057585", "26166432"]}, {"Citation": "Ahmad S, Iftikhar F, Ullah F, Sadiq A, Rashid U. Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors. Bioorg Chem. 2016;69:91\u2013101. doi:10.1016/j.bioorg.2016.10.002", "ArticleIdList": ["10.1016/j.bioorg.2016.10.002", "27750058"]}, {"Citation": "Shah S, Shah SMM, Ahmad Z, et al. Phytochemicals, in vitro antioxidant, total phenolic contents and phytotoxic activity of cornus macrophylla wall bark collected from the North-West of Pakistan. Pak J Pharm Sci. 2015;28(1):23\u201328.", "ArticleIdList": ["25553682"]}, {"Citation": "Jabeen M, Ahmad S, Shahid K, et al. Ursolic acid hydrazide based organometallic complexes: synthesis, characterization, antibacterial, antioxidant, and docking studies. Front Chem. 2018;6:55. doi:10.3389/fchem.2018.00055", "ArticleIdList": ["10.3389/fchem.2018.00055", "PMC5857580", "29594100"]}, {"Citation": "Zeb A, Sadiq A, Ullah F, Ahmad S, Ayaz M. Investigations of anticholinesterase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus. Biol Res. 2014;47(1):76. doi:10.1186/0717-6287-47-76", "ArticleIdList": ["10.1186/0717-6287-47-76", "PMC4297394", "25723481"]}, {"Citation": "Zafar R, Ullah H, Zahoor M, et al. Isolation of bioactive compounds from Bergenia ciliata (haw.) Sternb rhizome and their antioxidant and anticholinesterase activities. BMC Complement Altern Med. 2019;19(1):296. doi:10.1186/s12906-019-2679-1", "ArticleIdList": ["10.1186/s12906-019-2679-1", "PMC6833214", "31694704"]}, {"Citation": "Kumkrai P, Weeranantanapan O, Chudapongse N. Antioxidant, alpha-glucosidase inhibitory activity and sub-chronic toxicity of Derris reticulata extract: its antidiabetic potential. BMC Complement Altern Med. 2015;15:35. doi:10.1186/s12906-015-0552-4", "ArticleIdList": ["10.1186/s12906-015-0552-4", "PMC4354750", "25887793"]}, {"Citation": "Farooq U, Naz S, Shams A, et al. Isolation of dihydrobenzofuran derivatives from ethnomedicinal species polygonum barbatum as anticancer compounds. Biol Res. 2019;52(1):1. doi:10.1186/s40659-018-0209-0", "ArticleIdList": ["10.1186/s40659-018-0209-0", "PMC6322347", "30612577"]}, {"Citation": "Jabeen M, Choudhry MI, Miana GA, et al. Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents. Steroids. 2018;136:22\u201331. doi:10.1016/j.steroids.2018.05.008", "ArticleIdList": ["10.1016/j.steroids.2018.05.008", "29772243"]}, {"Citation": "Sramek JJ, Frackiewicz EJ, Cutler NR. Review of the acetylcholinesterase inhibitor galanthamine. Expert Opin Investig Drugs. 2000;9(10):2393\u20132402. doi:10.1517/13543784.9.10.2393", "ArticleIdList": ["10.1517/13543784.9.10.2393", "11060814"]}, {"Citation": "Carreiro EP, Louro P, Adriano G, et al. 3-hydroxypyrrolidine and (3, 4)-dihydroxypyrrolidine derivatives: inhibition of rat intestinal \u03b1-glucosidase. Bioorg Chem. 2014;54:81\u201388. doi:10.1016/j.bioorg.2014.04.007", "ArticleIdList": ["10.1016/j.bioorg.2014.04.007", "24859324"]}, {"Citation": "Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984.", "ArticleIdList": ["6496779"]}, {"Citation": "Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. \u03b2-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer\u2032 s disease. Biochem Biophys Res Commun. 1994;200(2):710\u2013715. doi:10.1006/bbrc.1994.1508", "ArticleIdList": ["10.1006/bbrc.1994.1508", "8179604"]}, {"Citation": "Wolff S. Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull. 1993;49(3):642\u2013652. doi:10.1093/oxfordjournals.bmb.a072637", "ArticleIdList": ["10.1093/oxfordjournals.bmb.a072637", "8221029"]}, {"Citation": "Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084(1):1\u201329. doi:10.1196/annals.1372.029", "ArticleIdList": ["10.1196/annals.1372.029", "17151290"]}, {"Citation": "Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab. 2006;91(3):837\u2013842. doi:10.1210/jc.2005-1566", "ArticleIdList": ["10.1210/jc.2005-1566", "16368744"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "5"}, {"Year": "2020", "Month": "3", "Day": "23"}, {"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["32606589", "PMC7285812", "10.2147/DDDT.S237420", "237420"]}}]}